Young Jin Tak

Dr. Young Jin Tak


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2021 in Current Obesity Reports
Verified
Journal Article
Closed access
PDF file
YTYoung Jin Tak
Young Jin Tak
Sang Yeoup LeeSang Yeoup Lee
Sang Yeoup Lee

1 January 2021 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
YTYoung Jin Tak
Young Jin Tak
Sang Yeoup LeeSang Yeoup Lee
Sang Yeoup Lee
Tak YJ, et al. World J Mens Health. 2020 Jan;38:e14. https://doi.org/10.5534/wjmh.200010

28 August 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
YTYoung Jin Tak
Young Jin Tak
JLJeong Gyu Lee
Jeong Gyu Lee
YYYu Hyeon Yi
Yu Hyeon Yi
YKYun Jin Kim
Yun Jin Kim
Sang Yeoup LeeSang Yeoup Lee
Sang Yeoup Lee
Young Hye ChoYoung Hye Cho
Young Hye Cho
To evaluate associations between handgrip strength (HGS) and dietary nutrients, this study of a representative Korean population of 1553 adults aged ≥60 years (706 men and 847 women) analyzed data from the Korea National Health and Nutrition Examination Survey (2016). HGS was measured in both hands three times using a digital grip strength dynamometer. Dietary intake data were collected by the 24-h recall method through computer-assisted personal interviews. The study population had a mean age of 70.1 years, body mass index (BMI) of 24.2 kg/m2, and HGS of 35.7 kg in men, 21.2 kg in women. Total energy (r = 0.411), protein (r = 0.217), polyunsaturated fatty acid (PUFA) (r = 0.269), fiber (r = 0.272), and vitamin C (r = 0.098) were positively correlated with HGS. In multivariable regression analysis, PUFA (β = 0.083) and vitamin C (β = 0.003) were positively associated with HGS among women. Fiber (β = 0.071) and vitamin C (β = 0.006) showed a positive association with HGS among men. Community-dwelling older men and women with higher levels of PUFA, fiber, and vitamin C in their diet were more likely to have greater HGS even after adjusting for age, total calorie intake, BMI, chronic diseases and health-related habits.

18 June 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
UHUp Huh
Up Huh
YTYoung Jin Tak
Young Jin Tak
SSSeunghwan Song
Seunghwan Song
SCSung Woon Chung
Sung Woon Chung
SSSang Min Sung
Sang Min Sung
HAHyo Yeong Ahn
Hyo Yeong Ahn
Background: Little is known of the effect of wearable devices on metabolic impairments in clinical settings. We hypothesized that a wearable device that can monitor and provide feedback on physical activity may help resolve metabolic syndrome. Objective: This study aimed to examine the objective effects of the use of these devices on metabolic syndrome resolution. Methods: Patients diagnosed with metabolic syndrome were recruited. Participants were prescribed regular walking using a wearable device (Coffee WALKIE +Dv.3, GC Healthcare CI, Korea) on their wrist for 12 weeks. Participants received self-feedback on the amount of their exercise through an app on their mobile phone. The information on physical activities of the participants was uploaded automatically to a website. Thus, a trained nurse could provide individuals with feedback regarding the physical activity via telephone consultation on alternate weeks. Blood pressure (BP), body composition, fasting plasma glucose, and lipid profiles were recorded. The primary outcome was metabolic syndrome resolution. The secondary outcome was an improvement in the components of metabolic impairment. Results: Of the 53 participants recruited, 20 participants with a median age of 46 (range 36-50) years completed the trial. There was no significant difference in the amount of calorie expenditure at weeks 4, 8, and 12. After 12 weeks, metabolic syndrome was resolved in 9 of 20 participants (45%), and the mean number of metabolic impairment components per person decreased from 3.4 to 2.9. Particularly, the mean systolic and diastolic BP decreased from mean 136.6 (SD 18.5) mm Hg to mean 127.4 (SD 19.5) mm Hg and from mean 84.0 (SD 8.1) mm Hg to mean 77.4 (SD 14.4) mm Hg (both P=.02), respectively. Conclusions: This study found that a 12-week intervention via feedback, based on a wearable physical activity monitor, helped metabolic syndrome patients to be more engaged in regular walking and it improved impaired metabolic components, especially in BP. However, some practical challenges regarding patients’ adherence and sustained engagement were observed.

7 March 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
YTYoung Jin Tak
Young Jin Tak
YKYun Jin Kim
Yun Jin Kim
JLJeong Gyu Lee
Jeong Gyu Lee
YYYu-Hyun Yi
Yu-Hyun Yi
Young Hye ChoYoung Hye Cho
Young Hye Cho
Sang Yeoup LeeSang Yeoup Lee
Sang Yeoup Lee
Recent animal studies found the potential of a collagen peptide derived from skate skin to have anti-obesity effects through the suppression of fat accumulation and regulation of lipid metabolism. However, no studies have yet been performed in humans. Here, this very first human randomized, placebo-controlled, and double-blinded study was designed to investigate the efficacy and tolerability of skate skin collagen peptides (SCP) for the reduction of body fat in overweight adults. Ninety healthy volunteers (17 men) aged 41.2 ± 10.4 years with a mean body mass index of 25.6 ± 1.9 kg/m2 were assigned to the intervention group (IG), which received 2000 mg of SCP per day or to the control group (CG) given the placebo for 12 weeks and 81 (90%) participants completed the study. Changes in body fat were evaluated using dual energy X-ray absorptiometry as a primary efficacy endpoint. After 12 weeks of the trial, the percentage of body fat and body fat mass (kg) in IG were found to be significantly better than those of subjects in CG (−1.2% vs. 2.7%, p = 0.024 and −1.2 kg vs. 0.3 kg, p = 0.025). Application of SCP was well tolerated and no notable adverse effect was reported from both groups. These results suggest the beneficial potential of SCP in the reduction of body fat in overweight adults.

11 June 2015 in Clinical Hypertension
Verified
Journal Article
Open access
PDF file
HHHye-Rim Hwang
Hye-Rim Hwang
JLJeong Gyu Lee
Jeong Gyu Lee
SLSangyeop Lee
Sangyeop Lee
KCKwang Soo Cha
Kwang Soo Cha
JCJung Hyun Choi
Jung Hyun Choi
YKYun-Jin Kim
Yun-Jin Kim
Hypertension is a significant risk factor for cardiovascular disease (CVD). The majority of patients, however, cannot easily maintain a healthy blood pressure. Therefore, lifestyle modifications are important and may include getting enough sleep. The purpose of this study was to determine the relationship between sleep duration and hypertension, as defined by the Joint National Committee (JNC) 7 and JNC 8 guidelines. We used the data from 6,365 individuals aged ≥ 18 years based on national data from a representative sample of the 5th Korea National Health and Nutrition Examination Survey V-3 in 2012. The participants were divided into three categories: JNC 7, JNC 8, and newly excluded only. The duration of sleep was classified as less than 5, 6, 7, 8, or more than 9 hours. Compared with the appropriate sleep duration of 7 hours, with a sleep duration of less than 5 hours, the recommended pharmacological treatment of hypertension rate increased 1.908-fold (95% CI = 1.483-2.456) according to the JNC 8 guidelines and 1.864-fold (95% CI = 1.446-2.403) according to the JNC 7 guidelines. However, there was no statistical difference with the other sleep categories. The recommended hypertension treatment rate increased significantly in the less than 5 hours sleep group according to the JNC 8 guidelines. To manage hypertension effectively, it may be useful to maintain a lifestyle of sleeping more than 6 hours.